Inventor
Jeffrey O. Saunders
Inventor
Lincoln, MA, US
Overview
Patents· 64 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02PClimate change mitigation technologies in the production or processing of goods3%
C07BGeneral methods of organic chemistry2%
Y02ATechnologies for adaptation to climate change2%
A61BDiagnosis1%
A61LMethods or apparatus for sterilising materials or objects in general1%
PatentTitleYear
10,988,448Therapeutic compounds and compositions202110,689,375Compounds and their methods of use202010,610,125Methods and compositions for cell-proliferation-related disorders202010,414,740Glutaminase inhibitors and method of use201910,294,215Therapeutically active compounds and their methods of use201910,202,339Therapeutic compounds and compositions201910,087,169Bicyclic PKM2 activators201810,087,172Compounds and their methods of use201810,029,987Therapeutic compounds and compositions201810,011,574Glutaminase inhibitors and method of use20189,938,259Therapeutic compositions and related methods of use20189,856,279'Therapeutically active compositions and their methods of use'20189,732,062'Therapeutically active compounds and their methods of use'20179,662,327'Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer'20179,657,004'Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use'20179,656,999'Therapeutically active compounds and their methods of use'20179,512,107'Therapeutically active compositions and their methods of use'20169,458,132'Therapeutic compounds and compositions and their use as PKM2 modulators'20169,328,077'Bicyclic PKM2 activators'20169,309,227'N-biphenylmethylbenzimidazole modulators of PPARG'20169,303,002'Compounds and their methods of use'20169,221,792'N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators'20159,199,968'Therapeutic compounds and compositions'20159,115,086'Therapeutic compositions and related methods of use'20159,029,531'Compounds and their methods of use'20158,889,667'Therapeutic compounds and compositions'20148,785,450'Therapeutic compounds and compositions'20148,742,119'Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use'20148,501,953'PKM2 modulators for use in the treatment of cancer'20138,268,873'Inhibitors of IMPDH enzyme'20127,989,498'Inhibitors of IMPDH enzyme'20117,919,520'Inhibitors of tace'20117,897,765'Therapeutic compounds and uses thereof'20117,829,589'Sulfonamide compounds and uses thereof'20107,504,506'Therapeutic compounds and uses thereof'20097,485,664'Inhibitors of TACE'20097,439,249'Inhibitors of phosphatases'20087,432,292'Sulfhydantoins as phosphate isosteres'20087,432,290'Inhibitors of IMPDH enzyme'20087,329,681'Inhibitors of IMPDH enzyme'20087,087,642'Inhibitors of IMPDH enzyme'20066,967,214'Inhibitors of IMPDH enzyme'20056,653,309'Inhibitors of IMPDH enzyme technical field of the invention'20036,541,496'Inhibitors of IMPDH enzyme'20036,518,291'Inhibitors of IMPDH enzyme'20036,498,178'Inhibitors of IMPDH enzyme'20026,344,465'Inhibitors of IMPDH enzyme'20026,054,472'Inhibitors of IMPDH enzyme'20005,935,954'Compounds with improved multi-drug resistance activity'19995,932,600'Inhibitors of IMPDH enzyme'19995,807,876'Inhibitors of IMPDH enzyme'19985,723,459'Biologically active acylated amino acid derivatives'19985,717,092'Compounds with improved multi-drug resistance activity'19985,665,774'Immunosuppressive compounds'19975,622,970'Immunosuppressive compounds'19975,620,971'Biologically active acylated amino acid derivatives'19975,516,797'Immunosuppressive compounds'19965,330,993'Immunosuppressive compounds'19945,264,455'Sulfur-substituted mevinic acid derivatives'19935,192,773'Immunosuppressive compounds'19935,173,487'Mevinic acid derivatives'19925,166,364'Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same'19925,099,035'Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same'19925,001,148'Mevinic acid derivatives'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1992Based in Holland, PA, US· patent location history
1993–2012Patents assigned to VERTEX PHARMA (26)· patent assignee history
1993–2012Based in Acton, MA, US· patent location history
1993–1997Based in Littleton, MA, US· patent location history
2011–2014Based in Concord, MA, US· patent location history
2012–2017Patents assigned to SAUNDERS JEFFREY O (10)· patent assignee history
2013–2021Patents assigned to AGIOS PHARMACEUTICALS INC (28)· patent assignee history
2013–2017Patents assigned to SALITURO FRANCESCO G (11)· patent assignee history
2013–2021Based in Lincoln, MA, US· patent location history
2014–2017Patents assigned to YAN SHUNQI (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AGIOS PHARMACEUTICALS INC | 28 | 2013–2021 |
| VERTEX PHARMA | 26 | 1993–2012 |
| SALITURO FRANCESCO G | 11 | 2013–2017 |
| SAUNDERS JEFFREY Oself | 10 | 2012–2017 |
| YAN SHUNQI | 6 | 2014–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lincoln, Massachusetts, US | 28 | 2013–2021 |
| Acton, Massachusetts, US | 27 | 1993–2012 |
| Littleton, Massachusetts, US | 3 | 1993–1997 |
| Holland, Pennsylvania, US | 3 | 1991–1992 |
| Concord, Massachusetts, US | 2 | 2011–2014 |